Neurodegenerative Diseases Clinical Trial
— CANVASOfficial title:
Evaluation of the Peripheral Nerve Ultrasound as a Diagnostic Tool in CANVAS (Cerebellar Ataxia With Neuropathy and Vestibular Areflexia Syndrome) Neuronopathies
Verified date | May 2022 |
Source | Centre Hospitalier Universitaire de Nimes |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
Cerebellar ataxia with neuropathy and bilateral areflexia syndrome (CANVAS) is a late onset neurodegenerative disorder with a slowly progressive ataxia. It's genetic causative etiology with an autosomal recessive inheritance has a recent discovery. It is clinically characterized by impaired visually enhanced vestibulo-ocular reflex, although patients commonly present with imbalance as a main concern, associated with sensory complaints. It has been demonstrated that sensory impairment in CANVAS patients is due to degeneration of dorsal root with abnormal sensory nerve conduction. Previously defined diagnostic criteria included cerebellar atrophy on brain MRI, neuronopathy on electrophysiological studies and negative genetic testing for other inherited ataxia syndromes like Friedriech ataxia and spinal cerebellar ataxia (SCA). Peripheral nerve ultrasound is a noninvasive technique, able to identify abnormal peripheral nerves with underlying injuries and specific sonographic characteristics. Pelosi et al established that patients with CANVAS have a smaller nerve cross sectional area (CSA) compared to healthy individuals and/ or axonal neuropathies. The main objective of this study was to obtaine a detailed description of peripheral nerves in consecutive patients with CANVAS syndrome followed in theneurology department of the Universitary Hospital of Nimes (France), using conventional electrophysiology and peripheral nerve ultrasound.
Status | Completed |
Enrollment | 35 |
Est. completion date | March 30, 2022 |
Est. primary completion date | March 30, 2022 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | CANVAS Patients : Inclusion Criteria: - Patients followed at the University Hospital of Nîmes between 2018-2021 - Age > 18 years - Diagnosis of CANVAS with genetic evidence (RFC1+) - Diagnosis of neuronopathy Exclusion Criteria: - Age <18 years - Chronic polyradiculoneuritis or other demyelinating neuropathy Control group, inclusion criteria : Patient with axonal sensory-motor or pure sensory neuropathy confirmed by electro neuromyography, and concordant with the clinic. |
Country | Name | City | State |
---|---|---|---|
France | CHU de Nîmes | Nîmes |
Lead Sponsor | Collaborator |
---|---|
Centre Hospitalier Universitaire de Nimes |
France,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | median ultrasound | Comparison of axial cross-sectional area to Bilateral exploration of median nerve ultrasound | Baseline | |
Primary | ulnar nerve at wrist ultrasound | Comparison of axial cross-sectional area to Bilateral exploration of ulnar nerve at wrist, ultrasound | Baseline | |
Primary | mid-arm ultrasound | Comparison of axial cross-sectional area to Bilateral exploration of ulnar nerve, mid-arm, ultrasound | Baseline | |
Primary | elbow ultrasound | Comparison of axial cross-sectional area to Bilateral exploration of ulnar nerve, elbow, ultrasound | baseline | |
Primary | ultrasound | Comparison of axial cross-sectional area to Bilateral exploration of ulnar nerve, mid-forearm, ultrasound | Day of the evaluation | |
Primary | radial nerve ultrasound | Comparison of axial cross-sectional area to Bilateral exploration of radial nerve ultrasound | Baseline | |
Primary | superficial radial branch nerve ultrasound | Comparison of axial cross-sectional area to Bilateral exploration of superficial radial branch nerve ultrasound | Baseline | |
Primary | C5, C6 ultrasound | Comparison of axial cross-sectional area to Bilateral exploration of C5, C6 roots ultrasound | Baseline | |
Primary | sural nerve ultrasound | Comparison of axial cross-sectional area to Bilateral exploration of sural nerve ultrasound | Baseline | |
Primary | superficial fibular nerve ultrasound | Comparison of axial cross-sectional area to Bilateral exploration of superficial fibular nerve ultrasound | Baseline | |
Primary | popliteus ultrasound | Comparison of axial cross-sectional area to Bilateral exploration of popliteus tibial nerve at ankle ultrasound | Baseline | |
Primary | tibial ultrasound | Comparison of axial cross-sectional area to Bilateral exploration of tibial nerveat ankle ultrasound | Baseline | |
Primary | fibular ultrasound | Comparison of axial cross-sectional area to Bilateral exploration of fibular nerve at the neck ultrasound | Baseline |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05538455 -
Investigating ProCare4Life Impact on Quality of Life of Elderly Subjects With Neurodegenerative Diseases
|
N/A | |
Completed |
NCT05788133 -
The Role of Humanoid Robot in Neuropsychological Assessment and Cognitive Training.
|
N/A | |
Completed |
NCT05080777 -
Pilot Pragmatic Clinical Trial to Embed Tele-Savvy Into Health Care Systems
|
N/A | |
Completed |
NCT03295786 -
Clinical Study to Test the Safety of CDNF by Brain Infusion in Patients With Parkinson's Disease
|
Phase 1/Phase 2 | |
Recruiting |
NCT04265482 -
Community-based Cohort of Functional Decline in Subjective Cognitive Complaint Elderly
|
||
Not yet recruiting |
NCT02222779 -
Quantification of Transition Metals
|
N/A | |
Recruiting |
NCT01291550 -
Electronic Nose for Diagnosis of Neurodegenerative Diseases Via Breath Samples
|
N/A | |
Completed |
NCT01450891 -
Health Technology Assessment of Diagnostic Approaches in Alzheimer's Disease
|
N/A | |
Completed |
NCT01953523 -
Safety and Clinical Outcomes Study: SVF Deployment for Orthopedic, Neurologic, Urologic, and Cardio-pulmonary Conditions
|
N/A | |
Recruiting |
NCT06148233 -
CSF1R PET Probe [18F]CSF-23 in Alzheimer's Disease Brain Imaging
|
N/A | |
Completed |
NCT03538522 -
A Double-Blind, Placebo-Controlled Safety and Efficacy Study of NA-831
|
Phase 2 | |
Completed |
NCT06251830 -
Increasing Diagnosis Rates While Reducing Examination Time: Can MR Fingerprinting Deliver on Its Promise?
|
||
Recruiting |
NCT04472130 -
Neurodegenerative Diseases Registry
|
||
Completed |
NCT03353207 -
Striatal Dopamine Transmission in Individuals With Isolated Rapid Eye Movement Sleep With Atonia: a Search for Precursor Biomarker for Neurodegeneration
|
||
Recruiting |
NCT05784090 -
Correlation Between Melatonin Levels in Different Biological Fluids
|
||
Completed |
NCT02108769 -
Yogic Breathing Changes Salivary Components
|
N/A | |
Recruiting |
NCT05508789 -
A Study of Donanemab (LY3002813) in Participants With Early Symptomatic Alzheimer's Disease (TRAILBLAZER-ALZ 5)
|
Phase 3 | |
Recruiting |
NCT05235802 -
Long-term Follow-up in Severe Traumatic Brain Injury
|
||
Recruiting |
NCT04820881 -
Cerebrovascular Reactivity and Oxygen Metabolism as Markers of Neurodegeneration After Traumatic Brain Injury
|
||
Completed |
NCT06180213 -
Study of Cerebral Glucose Metabolism in Neurodegenerative Diseases and Head Trauma
|